维普中文期刊产品整合服务
272篇 您的检索式:作者名="Kumar MS"
    题名 作者 年代 出处 被引量
1Patterns of cancer recurrence in localized resected hepatocellular carcinoma显示文摘BACKGROUND:Tumor resection in non-metastatic hepatocellular carcinoma(HCC)patients with adequate liver reserve offers a potential cure,but has a high 5-year recurrence rate.We analyzed the patterns of cancer relapse after partial hepatectomy to guide post-operative management.METHODS:A total of 144 HCC patients(1996-2011)after partial hepatectomy were reviewed.Statistical correlations were determined using univariate and partition analyses.RESULTS:A median follow-up of 20 months showed recurrence in 71(49%)patients,and the median time to recurrence was 11.9 months.Vascular invasion(P<0.01)and number of lesions(P<0.01)predicted for recurrence.Histologic grade was not correlated with recurrence.Twenty-two(31%)patients developed both surgical margin(SM)and concurrent intrahepatic recurrences,and 28(40%)had non-SM intrahepatic recurrences with no other signs of recurrence.On partition analysis,the risk of marginal recurrence in patients with SM<1 mm and SM≥1 mm was 35%and 13.5%respectively.Approximately 57%of patients with intrahepatic recurrence had recurrence≤2.5 cm from SM.CONCLUSIONS:Intrahepatic recurrence after partial hepatectomy is common and is significantly associated with vascular invasion and tumor stage.About 57%of patients with intrahepatic relapse had a recurrence close(≤2.5 cm)to the SM.Additionally,patients with SM<1 mm have a higher recurrence rate and may benefit from adjuvant local therapy.Aryavarta MS Kumar Elisha T Fredman Christopher Coppa Galal El-Gazzaz Federico N Aucejo May Abdel-Wahab 2015Hepatobiliary & Pancreatic Diseases International2015,14,3:7
2Silver - enhanced reduction of 2,3,5 - triphenyl - 2H - tetrazolium by semicarbazide for the spectrophotometric determination of traces of silver(I) 显示文摘Nagaraja P Hemantha Kumar MS Yathirajan HS 2002Anal Sci2002,18,7:1
3Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells显示文摘Olofsson B Korpelainen E Pepper MS Mandriota SJ Aase K Kumar V 1998Proc Natl Acad Sci USA1998,95,11:1
4Molecular regulation of vascular smooth muscle cell differentiation in development and disease显示文摘Owens GK Kumar MS Wamhoff BR 0,,03:1
5Impaired microRNA proeessing enhances cellular transformation and tumorigeneis显示文摘Kumar MS Lu J Mercer KL 2007Nat Genet2007,39,:1
6Utility of a column- switching LC/MS/MS method in cytochrome P450 inhibition assays using human liver microsomes 显示文摘Behera D Pattem R Kumar MS 2013Drug Metabol Drug Interact2013,28,3:1
7The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer显示文摘Kumar MS Hancock DC Molina-Arcas M 2012Cell2012,149,:1
8Suppression of non-small cell lung tumor development by the let-7 microRNA family显示文摘Kumar MS Erkeland SJ Pester RE 2008Proc Natl Acad Sci U S A2008,105,10:1
9Molecular regulation of vascular smooth muscle cell differentiation in development and disease显示文摘Owens GK Kumar MS Wamhoff BR 2004Physiol Rev2004,84,3:1
10Cranial polyneuropathy associated with vertebrobasilar dolichoectasia显示文摘Madhugiri VS Roopesh Kumar VR Gopalakrishnan MS 2012Clin Neurol Neurosurg2012,114,:1
11Innate immunity in theretina: Toll-like receptor ( TLR) signaling in human retinal pigmentepithelial cells 显示文摘Kumar MV Nagineni CN Chin MS et ai 2004J Neuroimmunol2004,153,:1
12Critical is- sues related to transfersomes-novel vesicular system 显示文摘Vinod KR Kumar MS Anbazhagan S 2012Acta Sci Pol TechnolAliment2012,11,1:1
13Impact of rtI233V mutation in hepatitis B virus polymerase protein and adefovir efficacy: Homology modeling and molecular docking studies 显示文摘Ismail AM Sharma OP Kumar MS 2013Bioinformation2013,9,3:1
14Impaired microRNA pro- cessing enhances cellular transformation and tumorigenesis显示文摘Kumar MS Lu J Mercer KL 2007Nat Genet2007,39,5:1
15Molecular regula- tion of vascular smooth muscle cell differentiation in devel- opment and disease 显示文摘Owens GK Kumar MS Warmhoff BR 2004Physiol Rev2004,84,3:1
16Engineering kunitz domain 1 ( KD1 ) of human tissue factor pathway inhibitor- 2 to selectively inhibit fibrinolysis: properties of KD1- L17R variant 显示文摘Bajaj MS Ogueli GI Kumar Y 2011Biol Chem2011,286,6:1
17Suppression of nonsmall cell lung tumor development by the let-7 microRNA family显示文摘Kumar MS Erkeland SJ Pester RE 2008Proc Natl Acad Sci USA2008,105,10:1
18Incomplete monosymptomatic leptomeningeal angiomatosis 显示文摘KumarS Muranjan MN Tullu MS 2004Indian J Pediatr2004,71,10:1
19CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine 显示文摘Kumar S Jones TR Oakley MS 2004Infect Immun2004,72,:1
20Intravitreous triameinolone acetonide as treatment for macularedema from central retinal vein occlusion 显示文摘Ip MS Kumar KS 2002Arch Ophthalmol2002,120,9:1
返回顶部 每页显示:
共14页 首页 上一页 第1页 下一页 末页 /14 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费